The behavioural and electrophysiological effects of CRF in rat frontal cortex

Neuropeptides

Volumn 42, Issue 5-6, 2008, Pages 513-523

  Zieba, Barbara ^a   Grzegorzewska, Małgorzata ^a   Brański, Piotr ^a   Domin, Helena ^a   Wierońska, Joanna M ^a   Hess, Grzegorz ^a   Śmiałowska, Maria ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Anxiety; CRF; Field potentials; Frontal cortex; Locomotor and exploratory activity; NMDA receptors

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 5 CHLORO 4 [N (CYCLOPROPYLMETHYL) N PROPYLAMINO] 2 METHYL 6 (2,4,6 TRICHLOROANILINO)PYRIMIDINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG INHIBITION; ELECTRIC POTENTIAL; ELECTROPHYSIOLOGY; EXPLORATORY BEHAVIOR; FRONTAL CORTEX; HISTOPATHOLOGY; IN VITRO STUDY; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; CORTICOTROPIN-RELEASING HORMONE; ELECTROPHYSIOLOGY; FRONTAL LOBE; MALE; MAZE LEARNING; MOTOR ACTIVITY; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

RATTUS;

EID: 56349169785     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2008.05.004     Document Type: Article

References (56)

1. Aroniadou V.A., and Keller A. The patterns and synaptic properties of horizontal intracortical connections in the rat motor cortex. J. Neurophysiol. 70 (1993) 1553-1569
2. Bakshi V.P., Smith-Roe S., Newman S.M., Grigoriadis D.E., and Kalin N.H. Reduction of stress-induced behavior by antagonism of corticotropin-releasing hormone 2 (CRH2) receptors in lateral septum or CRH1 receptors in amygdala. J. Neurosci. 22 7 (2002) 2926-2935
3. Baram T.Z., Chalmers D.T., Chen C., Koutsoukos Y., and De Souza E.B. The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist. Brain Res. 770 1-2 (1997) 89-95
4. Britton K.T., Lee G., Vale W., Rivier J., and Koob G.F. Corticotropin releasing factor (CRF) receptor antagonist blocks activating and anxiogenic actions of CRF in the rat. Brain Res. 369 1-2 (1986) 303-306
5. Buwalda B., de Boer S.F., Van Kalkeren A.A., and Koolhaas J.M. Physiological and behavioural effects of chronic intracerebroventricular infusion of corticotropin releasing factor in the rat brain. Psychoneuroendocrinology 22 5 (1997) 297-309
6. Carrasco G.A., and Van de Kar L.D. Neuroendocrine pharmacology of stress. Eur. J. Pharmacol. 463 (2003) 235-272
7. Cecchi M., Khoshbouei H., and Morilak D.A. Modulatory effects of norepinephrine, acting on alpha1 receptors in the central nucleus of the amygdala, on behavioral and neuroendocrine responses to acute immobilization stress. Neuropharmacology 43 (2002) 1139-1147
8. Chalmers D.T., Lovenberg T.W., Grigoriadis D.E., Behan D.P., and De Souza E.B. Corticotrophin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol. Sci. 17 4 (1996) 166-172
9. Chojnacka-Wojcik E., Klodzinska A., and Pilc A. Glutamate receptor ligands as anxiolytics. Curr. Opin. Investig. Drugs. 2 8 (2001) 1112-1119
10. Dautzenberg F.M., and Hauger R.L. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol. Sci. 23 2 (2002) 71-77
11. De Souza E.B. Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 20 8 (1995) 789-819
12. De Souza E.B., and Grigoriadis D.E. Corticotropin-releasing factor: physiology, pharmacology and role in central nervous system and immune disorders. In: Bloom F.E., and Kupfer D.J. (Eds). Psychopharmacology: The Fourth Generation of Progress (1995), Raven Press Ltd., New York 505-517 (Chapter 45)
13. Dunn A.J., and Berridge C.W. Physiological and behavioural responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?. Brain Res. Rev. 15 2 (1990) 71-100
14. Engler D., Redei E., and Kola I. The corticotropin-release inhibitory factor hypothesis: a review of the evidence for the existence of inhibitory as well as stimulatory hypophysiotropic regulation of adrenocorticotropin secretion and biosynthesis. Endocr. Rev. 20 4 (1999) 460-500
15. Froc D.J., and Christie B.R. Corticotrophin-releasing hormone decreases synaptic transmission in rat sensorimotor cortex in vivo. Neuroscience 134 (2005) 965-973
16. Fuxe K., Agnati L.F., Harfstrand A., Zini I., Tatemoto K., Pich E.M., Hokfelt T., Mutt V., and Terenius L. Central administration of neuropeptide Y induces hypotension, bradypnea and EEG synchronization in the rat. Acta Physiol. Scand. 118 (1983) 183-192
17. Grammatopoulos D.K., Randeva H.S., Levine M.A., Kanellopoulou K.A., and Hillhouse E.W. Rat cerebral cortex corticotropin releasing hormone receptors: evidence for receptor coupling to multiple G-proteins. J. Neurochem. 76 2 (2001) 509-519
18. Grzegorzewska M., Przybylo M., Litynska A., and Hess G. Chemically induced long-term potentiation in rat motor cortex involves activation of extracellular signal-regulated kinase cascade. Brain Res. 1021 2 (2004) 192-199
19. Harro J., Tonissaar M., and Eller M. The effects of CRA 1000, a non-peptide antagonist of corticotropin-releasing factor receptor type 1, on adaptive behaviour in the rat. Neuropeptides 35 2 (2001) 100-109
20. Hauger R.L., Grigoriadis D.E., Dallman M.F., Plotsky P.M., Vale W.W., and Dautzenberg F.M. International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands. Pharmacol. Rev. 55 1 (2003) 21-26
21. Heilig M., Koob G.F., Ekman R., and Britton K.T. Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci. 17 2 (1994) 80-85
22. Heilig M., McLeod S., Koob G.K., and Britton K.T. Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test. Regul. Peptid. 41 (1992) 61-69
23. Heilig M., Soderpalm B., Engel J.A., and Widerlov E. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology 98 (1989) 524-529
24. Heilig M., and Murison R. Intracerebroventricular neuropeptide Y suppresses home cage and open field activity in the rat. Regul. Peptid. 19 (1987) 221-231
25. Heinrichs S.C., Pich E.M., Miczek K.A., Britton K.T., and Koob G.F. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action. Brain Res. 581 2 (1992) 190-197
26. Hess G., Aizenman C.D., and Donoghue J.P. Conditions for the induction of long-term potentiation in layer II/III horizontal connections of the rat motor cortex. J. Neurophysiol. 75 (1996) 1765-1778
27. Hess G., and Donoghue J.P. Long-term potentiation of horizontal connections provides a mechanism to reorganize cortical motor maps. J. Neurophysiol. 71 (1994) 2543-2547
28. Hess G., Jacobs K.M., and Donoghue J.P. N-methyl-d-aspartate receptor-mediated component of field potentials evoked in horizontal pathways of rat motor cortex. Neuroscience 61 (1994) 225-235
29. Hillhouse E.W., Randeva H., Ladds G., and Grammatopoulos D. Corticotropin-releasing hormone receptors. Biochem. Soc. Trans. 30 4 (2002) 428-432
30. Kash T.L., and Winder D.G. Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropharmacology 51 (2006) 1013-1022
31. Kolb B. Functions of the frontal cortex of the rat: a comparative review. Brain Res. 320 1 (1984) 65-98
32. Leger J.F., Stern E.A., Aertsen A., and Heck D. Synaptic integration in rat frontal cortex shaped by network activity. J. Neurophysiol. 93 (2005) 281-293
33. Liu J., Yu B., Neugebauer V., Grigoriadis D.E., Rivier J., Vale W.W., Shinnick-Gallagher P., and Gallagher J.P. Corticotropin-releasing factor and urocortin I modulate excitatory glutamatergic synaptic transmission. J. Neurosci. 24 (2004) 4020-4029
34. Lovenberg T.W., Liaw C.W., Grigoriadis D.E., Clevenger W., Chalmers D.T., De Souza E.B., and Oltersdorf T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. USA 92 3 (1995) 836-840
35. Lowry C.A., and Moore F.L. Regulation of behavioural responses by corticotropin-releasing factor. Gen. Comp. Endocrinol. 146 1 (2006) 19-27
36. Millan M.J. The neurobiology and control anxious states. Progr. Neurobiol. 70 (2003) 83-244
37. Owens M.J., and Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 43 4 (1991) 425-473
38. Paxinos C., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, London
39. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Meth. 14 3 (1985) 149-167
40. Perrin M., Donaldson C., Chen R., Blount A., Berggren T., Bilezikjian L., Sawchenko P., and Vale W. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc. Natl. Acad. Sci. USA 92 7 (1995) 2969-2973
41. Rassnick S., Heinrichs S.C., Britton K.T., and Koob G.F. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res. 605 1 (1993) 25-32
42. Rivier C., Brownstein M., Spiess J., Rivier J., and Vale W. In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, beta-endorphin, and corticosterone. Endocrinology 110 1 (1982) 272-278
43. Sahuque L.L., Kullberg E.F., Mcgeehan A.J., Kinder J.R., Hicks M.P., Blanton M.G., Janak P.H., and Olive M.F. Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes. Psychopharmacology (Berl) 186 1 (2006) 122-132
44. Sakanaka M., Shibasaki T., and Lederis K. Corticotropin releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidase-diaminobenzidine method. J. Compar. Neurol. 260 (1987) 256-298
45. Segal M. The action of serotonin in the rat hippocampal slice preparation. J. Physiol. 303 (1980) 423-439
46. Spina M.G., Merlo-Pich E., Akwa A., Balducci C., Basso A.M., Zorrilla E.P., Britton K.T., Rivier J., Vale W.W., and Koob G.F. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat. Psychopharmacology 160 (2002) 113-121
47. Sutton R.E., Koob G.F., Le Moal M., Rivier J., and Vale W.W. Corticotropin releasing factor produces behavioural activation in rats. Nature 297 (1982) 331-333
48. Swanson L.W., Sawchenko P.E., Rivier J., and Vale W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36 3 (1983) 165-186
49. Smialowski A., Lewinska-Gastol L., and Smialowska M. The behavioural effects of neuropeptide Y (NPY) injection into the rat brain frontal cortex. Neuropeptides 21 3 (1992) 153-156
50. Takahashi L.K. Role of CRF1 and CRF2 receptors in fear and anxiety. Neurosci. Biobehav. Rev. 25 7-8 (2001) 627-636
51. Tan H., Zhong P., and Yan Z. Corticotropin-releasing factor and acute stress prolongs serotonergic regulation oaf GABA transmission in prefrontal cortical pyramidal neurons. J. Neurosci. 24 (2004) 5000-5008
52. Tanaka M., Yoshida M., Emoto H., and Ishii H. Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies. Eur. J. Pharmacol. 405 (2000) 397-406
53. Wang H.L., Wayner M.J., Chaii C.Y., and Lee E.H. Corticotropin-releasing factor produces a long-lasting enhancement of synaptic efficacy in the hippocampus. Eur. J. Neurosci. 10 (1998) 3428-3437
54. Wieronska J.M., Szewczyk B., Palucha A., Branski P., and Smialowska M. Involvement of CRF but not NPY in the anxiety regulation via NMDA receptors. Pol. J. Pharmacol. 55 6 (2003) 1119-1124
55. Wieronska J.M., Branski P., Palucha A., and Smialowska M. The effect of competitive and non-competitive NMDA receptor antagonists, ACPC and MK-801 on NPY and CRF-like immunoreactivity in the rat brain amygdala. Neuropeptides 35 5-6 (2001) 219-226
56. Zilles K., and Wree A. Cortex: areal and laminar structure. In: Paxinos G. (Ed). The Rat Nervous System. second ed. (1995), Academic Press, San Diego, USA 649-685